The report provides a detailed analysis essential for establishing a bisacodyl production plant. It encompasses all critical aspects necessary for bisacodyl production, including the cost of bisacodyl production, bisacodyl plant cost, bisacodyl production costs, and the overall bisacodyl production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a bisacodyl production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Bisacodyl is a widely used pharmaceutical compound that finds its main application as a stimulant laxative. It is primarily used in the treatment of constipation by stimulating bowel movements and promoting intestinal activity. It works by stimulating the muscles in the bowel to produce movement, which helps stool pass more easily. It is commonly used for short-term relief of occasional constipation. It is formulated into tablets, suppositories, and oral solutions, which makes it suitable for both short-term therapeutic use and controlled medical supervision. It is also widely prescribed for bowel preparation before medical procedures like colonoscopy, radiographic examinations, and intestinal surgeries to ensure complete bowel evacuation. In hospitals and clinical settings, it is used to manage constipation caused by prolonged bed rest, post-surgical recovery, or the use of certain medications.
The primary factor that drives the market for bisacodyl is its demand as a stimulant laxative for the relief of occasional constipation and bowel preparation before medical examinations like colonoscopy. Its application as a bowel-cleansing agent before medical procedures such as colonoscopies and certain surgeries also boosts its demand in the healthcare and pharmaceutical industries. Its demand as a laxative in management and bowel preparation in clinical settings significantly contributes to its market expansion. Its usage in both prescription and over-the-counter laxative formulations also enhances its accessibility and demand across hospitals, diagnostic centres, and home care settings. Moreover, the rising prevalence of digestive health issues, ageing populations, and increasing awareness of gastrointestinal wellness further boost its demand. Additionally, industrial bisacodyl procurement is defined by several key factors, including the availability and pricing of active pharmaceutical ingredients, regulatory approvals, and adherence to health and safety standards. Technological developments in drug formulation, reliability of supply chains, eco-friendly production practices, and smooth global distribution networks also play a crucial role in shaping the market trends for Bisacodyl procurement worldwide.
Raw Material for Bisacodyl Production
According to the bisacodyl production plant project report, the major raw materials for bisacodyl production include 2-pyridinecarboxaldehyde, phenol, acetic anhydride, and anhydrous sodium acetate.
Production Process of Bisacodyl
The extensive bisacodyl production cost report consists of the following industrial production process:
- Production via Condensation: The production process of bisacodyl begins with the condensation of 2-pyridinecarboxaldehyde with phenol in the presence of sulfuric acid, which facilitates the formation of a diphenylmethane-type intermediate through electrophilic aromatic substitution. Then, this intermediate undergoes esterification using acetic anhydride in the presence of anhydrous sodium acetate, which leads to the formation of bisacodyl, a diphenylmethane derivative. After completion of the reaction, the resulting product is purified to remove residual reagents and by-products, resulting in the formation of bisacodyl as the final product.
Bisacodyl is a diphenylmethane derivative that functions as a stimulant laxative. It appears as a white to off-white crystalline powder that is odourless. The molecular formula of the compound is C22H19NO4, and its molar mass is 361.39 g/mol. It has a density of approximately 1.2 g/cm³, and it is practically insoluble in water but slightly soluble in alcohol and ether, while being soluble in chloroform and acetone. The melting point of the compound ranges from 131 degree Celsius to 135 degree Celsius, and its boiling point is approximately 492 degree Celsius at 760 mmHg. The compound is chemically stable under controlled storage conditions and should be protected from light and moisture. It works by stimulating enteric neurons in the colon to produce peristalsis and increase colonic motility. It emits toxic vapours of nitrogen oxides upon being heated to decomposition. The compound is available in various dosage forms, including tablets, suppositories, and enemas, and is marketed under well-known trade names such as Dulcolax and Correctol.